Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496374/
https://www.ncbi.nlm.nih.gov/pubmed/34615707
http://dx.doi.org/10.1136/jitc-2021-003149corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496374/
https://www.ncbi.nlm.nih.gov/pubmed/34615707
http://dx.doi.org/10.1136/jitc-2021-003149corr1

Ejemplares similares